v3.26.1
SCHEDULE OF OPTION ACTIVITY FOR BEYOND CANCER (Details) - 2021 Beyond Cancer Ltd Equity Incentive Plan [Member] - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Options, Outstanding at beginning of period 2,816,250 3,819,000  
Weighted Average Exercise Price - Options, Outstanding at beginning of period $ 5.50 $ 5.50  
Weighted average remaining contractual life - options, outstanding at beginning of period 6 years 2 months 12 days 7 years 2 months 12 days 8 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding at beginning of period  
Number of Options, Granted  
Weighted Average Exercise Price of Options, Granted  
Number of Options, Exercised  
Weighted Average Exercise Price of Options, Exercised  
Number of Options, Forfeited (561,750) (1,002,750)  
Weighted Average Exercise Price of Options, Forfeited $ 5.50 $ 5.50  
Number of Options, Outstanding at ending of period 2,254,500 2,816,250 3,819,000
Weighted Average Exercise Price - Options, Outstanding at ending of period $ 5.50 $ 5.50 $ 5.50
Aggregate Intrinsic Value, Outstanding at end of period
Number of Options Outstanding, Exercisable 1,975,750    
Weighted Average Exercise Price - Options, Exercisable $ 5.50    
Weighted Average Remaining Contractual Life of Options, Exercisable 6 years 1 month 6 days    
Aggregate Intrinsic Value, Exercisable